Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Drug
Clover Biopharmaceuticals Administers First Dose of COVID-19 Vaccine SCB-2019 in Zhejiang
January 19, 2025
Company
Deals
Hengrui Pharmaceuticals Licenses SHR2554 to Treeline Biosciences
January 19, 2025
Company
Deals
CSPC Pharmaceutical Licenses ADC SYS6002 to Corbus Pharmaceuticals
January 19, 2025
Company
Deals
Mingche Biotechnology Secures Pre-Series A Funding for Medical Device Innovation
January 19, 2025
Company
Deals
Dessight Biomedical Secures Pre-Series A Funding for Ophthalmic Innovations
January 19, 2025
Company
Drug
Luye Pharma Initiates Phase I Study for BA1106, a CD25 Monoclonal Antibody
January 19, 2025
Company
Drug
Zelgen’s ZGGS15 Accepted for NMPA Review as First Global BsAb Filing
January 19, 2025
Company
Drug
Kintor’s GT20029 Shows Positive Results in US Phase I Study for AGA and Acne
January 19, 2025
Company
Drug
Hengrui’s HER2-Targeted ADC SHR-A1811 Aims for Breakthrough Designation
January 19, 2025
Company
Drug
EOC Pharma’s CDK7 Inhibitor EOC237 Accepted for CDE Review
January 19, 2025
Company
Drug
Joincare’s Generic Seretide Accepted for NMPA Review
January 19, 2025
Company
Deals
Nona Biosciences Partners with Mythic Therapeutics for Next-Gen ADCs
January 19, 2025
1
2
…
1,033
1,034
1,035
1,036
1,037
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?